[Seite 108↓]

Literaturverzeichnis

1. Banner AS . The increase in asthma prevalence. Chest 1995 ;108 :301-302.

2. Beasley R, Crane J, Lai CK, Pearce N . Prevalence and etiology of asthma. J Allergy Clin Immunol 2000.Feb .;105.(2.Pt.2.): S466.-72 105:S466-S472

3. Burney P . Epidemiology of asthma . Allergy 1993;48:17-21.

4. Doyle R . Asthma worldwide. Sci.Am 2000.Jun 282.(6.): 30 282:30

5. Holgate ST. The epidemic of allergy and asthma. Nature 1999;402:B2-B4

6. Mitchell EA. Asthma epidemiology: clues and puzzles. Pediatr.Pulmonol.Suppl . 1999;18 :31-3.:31-33.

7. Mitka M. Why the rise in asthma? New insight, few answers. JAMA 1999;281:2171-2172.

8. Arm JP, Lee TH. The Pathobiology of Bronchial Asthma. Adv Immunol 1992 ;51:323-382.

9. Anonymous Global Initiative for Asthma: Global strategy for asthma management and prevention NHLBI/WHO workshop report National Heart, Lung and Blood Institute Publication No. 95-3659 January 1995 1995;

10. Cockcroft DW. Airway hyperresponsiveness in asthma. Hosp.Pract.(Off.Ed.) 1990;25:111-119.

11. Cockcroft DW. Bronchial inhalation tests. I. Measurement of nonallergic bronchial responsiveness. Ann.Allergy 1985; 55:527-534.

12. Cockcroft DW . Bronchial inhalation tests. II. Measurement of allergic (and occupational) bronchial responsiveness . Ann.Allergy 1987; 59:89-98.

13. Cockcroft DW, Marciniuk DD, Hurst TS, et al . Methacholine challenge: test-shortening procedures. Chest 2001.Dec 120.(6.): 1857.-60. 120:1857-1860.

14. de Jongste JC, Jongejan RC, Kerrebijn KF . Control of airway caliber by autonomic nerves in asthma and in chronic obstructive pulmonary disease. Am.Rev Respir.Dis 1991;143: 1421-1426.


[Seite 109↓]

15. de Jongste JC, Mons H, Bonta IL, Kerrebijn KF. Nonneural components in the response of fresh human airways to electric field stimulation. J Appl.Physiol. 1987 ;63 :1558-1566.

16. de Jongste JC, Mons H, Bonta IL, Kerrebijn KF . In vitro responses of airways from an asthmatic patient. Eur.J Respir.Dis 1987;71:23-29.

17. Benson MK. Bronchial hyperreactivity . Br.J Dis.Chest 1975;69:227-239.

18. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma . Am.Rev Respir.Dis 1989;139:242-246.

19. Hogg JC. Bronchial mucosal permeability and its relationship to airways hyperreactivity . J Allergy Clin Immunol 1981;67:421-425.

20. Hargreave FE, Dolovich J, O'Byrne PM, Ramsdale EH, Daniel EE. The origin of airway hyperresponsiveness. J Allergy Clin Immunol 1986; 78:825-832.

21. Parker CW, Smith JW. Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest 1973;52:48-59.

22. Conolly ME, Greenacre JK. The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function . J Clin Invest 1976;58:1307-1316.

23. Richardson PS, Sterling GM. Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects. Br.Med.J 1969;3:143-145.

24. Townley RG, McGeady S, Bewtra A. The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. J Allergy Clin Immunol 1976;57:358-366.

25. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness. Agents Actions Suppl 1987;21: 225-237.

26. Barnes PJ. Neural control of human airways in health and disease. Am.Rev Respir.Dis . 1986;134:1289-1314.

27. Barnes PJ. Neural mechanisms in asthma. Br.Med.Bull. 1992;48 :149-168.

28. Barnes PJ. Neural mechanisms in asthma: new developments. Pediatr.Pulmonol.Suppl 1997 ;16: 82-83.


[Seite 110↓]

29. Barnes PJ. Non-adrenergic non-cholinergic neural control of human airways. Arch Int Pharmacodyn.Ther 1986;280:208-228.

30. Lammers JW, Barnes PJ, Chung KF. Nonadrenergic, noncholinergic airway inhibitory nerves . Eur.Respir.J 1992;5:239-246.

31. Ward JK, Barnes PJ, Springall DR, et al. Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves. Am.J Respir.Cell Mol.Biol 1995;13:175-184.

32. Hogg JC, James AL, Pare PD. Evidence for inflammation in asthma. Am.Rev Respir.Dis 1991;143:S39-S42

33. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol.Rev 1998;50:515-596.

34. Chung KF. Mediators of bronchial hyperresponsiveness. Clin Exp Allergy 1990;20:453-458.

35. Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES. Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am.J.Respir.Crit.Care Med 1994;149:1506-1511.

36. Vincenc KS, Black JL, Yan K, Armour CL, Donnelly PD, Woolcock AJ. Comparison of in vivo and in vitro responses to histamine in human airways. Am.Rev Respir.Dis 1983;128:875-879.

37. Finnerty JP, Holgate ST. Evidence for the roles of histamine and prostaglandins as mediators in exercise-induced asthma: the inhibitory effect of terfenadine and flurbiprofen alone and in combination. Eur.Respir.J. 1990;3:540-547.

38. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J.Allergy Clin.Immunol 1990;85:422-436.

39. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J.Allergy Clin.Immunol. 1988;81:776-781.

40. Gleich GJ, Adolphson C. Bronchial hyperreactivity and eosinophil granule proteins. Agents Actions Suppl . 1993;43 :223-230.

41. Coyle AJ, Mitzner W, Irvin CG. Cationic proteins alter smooth muscle function by an epithelium- dependent mechanism . J Appl.Physiol 1993; 74: 1761-1768.


[Seite 111↓]

42. Coyle AJ, Ackerman SJ, Irvin CG. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am.Rev.Respir.Dis 1993;147 :896-900.

43. Coyle AJ, Uchida D, Ackerman SJ, Mitzner W, Irvin CG. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. [Review]. Am.J Respir.Crit.Care Med 1994;150: S63-71.

44. Jacoby DB, Gleich GJ, Fryer AD. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J.Clin.Invest. 1993;91:1314-1318.

45. Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J.Clin.Invest 1991 ;87 :1470-1473.

46. Bentley AM, Menz G, Storz C, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am.Rev.Respir.Dis. 1992;146:500-506.

47. Bienenstock J. An update on mast cell heterogeneity. J.Allergy Clin.Immunol. 1988 ;81:763-769.

48. Gibson PG, Allen CJ, Yang JP, et al. Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am.Rev.Respir.Dis 1996;148 :80-86.

49. Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. [Review]. Immunol.Today 1989;10:381-386.

50. Blank U, Ra C, Miller L, White K, Metzger H, Kinet JP. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 1989;337:187-189.

51. Presta L, Shields R, O'Connell L, et al. The binding site on human immunoglobulin E for its high affinity receptor. J Biol.Chem 1994;269 :26368-26373.

52. Galli SJ. New concepts about the mast cell. [Review]. N.Engl.J.Med. 1993;328:257-265.


[Seite 112↓]

53. Martin TR, Galli SJ, Katona IM, Drazen JM. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice . J Clin.Invest. 1989;83:1375-1383.

54. Casale TB, Wood D, Richerson HB, Zehr B, Zavala D, Hunninghake GW. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction . J.Clin.Invest. 1987;80: 1507-1511.

55. Corrigan CJ, Kay AB. The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. Am.Rev.Respir.Dis. 1991;143:1165-8; discussion 1175-6.

56. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. [Review]. Am.Rev.Respir.Dis. 1990;142:434-457.

57. Holgate ST, Kay AB. Mast cells, mediators and asthma. [Review]. Clin.Allergy 1985;15:221-234.

58. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am.Rev.Respir.Dis. 1989 ;139:806-817.

59. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994;105:687-696.

60. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 1991;3:865-872.

61. Galli SJ, Wershil BK, Gordon JR, Martin TR. Mast cells: immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses. [Review]. Ciba.Found.Symp. 1989;147:53-65; discussion 65-73.

62. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am.J.Respir.Cell Mol.Biol. 1995;12: 477-487.


[Seite 113↓]

63. Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am.Rev.Respir.Dis. 1985;132 :986-992.

64. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration [publihsed erratum appears in Am Rev Respir Dis 1990 Feb;141(2):518]. Am.Rev.Respir.Dis 1988;137:548-557.

65. Hutson PA, Holgate ST, Church MK. The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. Am.Rev.Respir.Dis. 1988;138:1157-1163.

66. Clutterbuck EJ, Sanderson CJ . Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL- 5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor. Blood 1990;75:1774-1779.

67. Lopez AF, Begley CG, Williamson DJ, Warren DJ, Vadas MA, Sanderson CJ. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J.Exp.Med . 1986;163:1085-1099.

68. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J.Exp.Med 1988;167: 219-224.

69. McKenzie AN, Barry SC, Strath M, Sanderson CJ. Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules. Embo J 1991;10:1193-1199.

70. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia . J Immunol 1997;158:3902-3908.

71. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5 . J.Immunol. 1992;148: 3543-3549.

72. Tai PC, Sun L, Spry CJ. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM- CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin.Exp.Immunol 1991; 85:312-316.


[Seite 114↓]

73. Bjerke T, Poulsen LK, Zionchek K, Nielsen LP, Kochan J, Jardieu P. Expression of the high-affinity immunoglobulin E receptor alpha-subunit in human blood eosinophils. Int Arch Allergy Immunol 1997;113:302-304.

74. Capron M, Bazin H, Joseph M, Capron A. Evidence for IgE-dependent cytotoxicity by rat eosinophils . J.Immunol. 1981;126: 1764-1768.

75. Capron M, Kusnierz JP, Prin L, et al. Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry . J.Immunol. 1985;134:3013-3018.

76. Capron M, Truong MJ, Aldebert D, et al. Heterogeneous expression of CD23 epitopes by eosinophils from patients. Relationships with IgE-mediated functions. Eur.J.Immunol 1991 ; 21:2423-2429.

77. Gounni AS, Lamkhioued B, Delaporte E, et al. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy?. [Review ]. J.Allergy Clin.Immunol 1994;94:1214-1216.

78. Gounni AS, Lamkhioued B, Ochiai K, et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367 :183-186.

79. Humbert M, Grant JA, Taborda-Barata L, et al. High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am.J Respir.Crit.Care Med 1996;153:1931-1937.

80. Truong MJ, Gruart V, Liu FT, Prin L, Capron A, Capron M. IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity. Eur.J.Immunol. 1993;23:3230-3235.

81. Moqbel R, Lacy P. New concepts in effector functions of eosinophil cytokines. Clin Exp.Allergy 2000.Dec.; 30.(12.): 1667.-71

82. Lacy P, Moqbel R. Eosinophil cytokines . Chem.Immunol 2000 76 134.-55.

83. Moqbel R. Eosinophil-derived cytokines in allergic inflammation and asthma. Ann.N.Y.Acad.Sci. 1996;796 :209-17

84. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1183-1188.


[Seite 115↓]

85. Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia--the key to asthma? Immunol Rev 2001.Feb .;179 182.-91

86. Kay AB. Eosinophils and asthma . N.Engl.J.Med. 1991;324: 1514-1515.

87. Kay AB, Corrigan CJ. Asthma. Eosinophils and neutrophils. Br.Med.Bull. 1992 ;48:51-64.

88. Abraham WM, Sielczak MW, Ahmed A, et al. Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep . J Clin.Invest. 1994 ;93:776-787.

89. Springer TA. Adhesion receptors of the immune system. Nature 1990 ;346:425-434.

90. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994;94:427-438.

91. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol. 1992;149:4021-4028.

92. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp.Med. 1994;179:1145-1154.

93. Rabb HA, Olivenstein R, Issekutz TB, Renzi PM, Martin JG. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Am.J Respir.Crit.Care Med. 1994;149:1186-1191.

94. Sano H, Nakagawa N, Nakajima H, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule-1 and platelet- activating factor in selective eosinophil migration across vascular endothelial cells. Int.Arch.Allergy Immunol. 1995;107: 533-540.

95. Taylor BM, Kolbasa KP, Chin JE, et al. Roles of adhesion molecules ICAM-1 and alpha4 integrin in antigen-induced changes in microvascular permeability associated with lung inflammation in sensitized brown Norway rats. Am.J Respir.Cell Mol.Biol. 1997;17:757-766.


[Seite 116↓]

96. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1 . J Immunol . 1992;148: 1086-1092.

97. Nickel R, Beck LA, Stellato C, Schleimer RP . Chemokines and allergic disease . J Allergy Clin Immunol 1999; 104 :723-742.

98. Uguccioni M. Chemokines and chemokine receptors in allergic diseases. Pediatr.Pulmonol.Suppl. 1999 ;18 113-114.

99. Rothenberg ME, Zimmermann N, Mishra A, et al. Chemokines and chemokine receptors: their role in allergic airway disease . J Clin Immunol 1999;19:250-265.

100. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392: 565-568.

101. Elsner J, Kapp A. The chemokine network in eosinophil activation. Allergy Asthma Proc.2001. May.-Jun.;22.(3.): 139.-48

102. Lloyd C. Chemokines in allergic lung inflammation. Immunology 2002 Feb.;105.(2.): 144.-54

103. Gonzalo JA, Lloyd CM, Wen D, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp.Med. 1998;188:157-167.

104.Jose, P. J., Griffiths/Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., and Williams, T. J. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation . J.Exp.Med. 179, 881-887. 1994.

105. Abraham WM, Ahmed A, Sielczak MW, Narita M, Arrhenius T, Elices MJ. Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4. Am.J Respir.Crit.Care Med . 1997;156 :696-703.

106. Chin JE, Winterrowd GE, Hatfield CA, et al. Involvement of intercellular adhesion molecule-1 in the antigen- induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation. Am.J Respir.Cell Mol.Biol . 1998;18: 158-167.


[Seite 117↓]

107. Pretolani M, Ruffie C, Lapa SJ, Joseph D, Lobb RR, Vargaftig BB. Antibody to very late activation antigen 4 prevents antigen- induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp.Med. 1994;180:795-805.

108. Wolyniec WW, De Sanctis GT, Nabozny G, et al. Reduction of antigen-induced airway hyperreactivity and eosinophilia in ICAM-1-deficient mice. Am.J Respir.Cell Mol.Biol . 1998;18: 777-785.

109. Hatfield CA, Brashler JR, Winterrowd GE, et al. Intercellular adhesion molecule-1-deficient mice have antibody responses but impaired leukocyte recruitment. Am.J Physiol 1997;273:L513-23.

110. Holt PG. Regulation of antigen-presenting cell function(s) in lung and airway tissues . Eur.Respir.J. 1993;6:120-129.

111. Pieters J. MHC class II restricted antigen presentation. Curr.Opin.Immunol 1997;9 :89-96.

112. Weenink SM, Gautam AM. Antigen presentation by MHC class II molecules. Immunol Cell Biol . 1997;75: 69-81.

113. Miller JF. Immune self-tolerance mechanisms. Transplantation 2001 Oct.27 72.(8.Suppl.) S5.-9

114. Sprent J, Kishimoto H. The thymus and central tolerance. Transplantation 2001.Oct.27.; 72.(8.Suppl.) S25.-8.

115. Guerder S, Flavell RA. T-cell activation. Two for T. Curr.Biol. 1995;5:866-868.

116. Olive D, van Lier R. CD28 and T-cell activation. Res.Immunol 1995;146:127-129.

117. Erb P, Kennedy M, Wassmer P, Huegli G. Antigen-presenting cells and T cell activation. Agents Actions 1986;19 :266-268.

118. Bentley AM, Maestrelli P, Saetta M, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J.Allergy Clin.Immunol. 1992 ;89:821-829.

119. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony- stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am.J.Respir.Cell Mol.Biol . 1993;8:35-42.


[Seite 118↓]

120. Bradley BL, Azzawi M, Jacobson M, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991 ;88:661-674.

121. Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1988; 1:1129-1132.

122. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am.Rev.Respir.Dis. 1990;141:970-977.

123. Kay AB, Durham SR. T-lymphocytes, allergy and asthma. Clin Exp Allergy 1991;1:17-21.

124. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J.Allergy Clin.Immunol. 1991;88:935-942.

125. Garlisi CG, Falcone A, Hey JA, et al. Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. Am.J Respir.Cell Mol.Biol. 1997;17:642-651.

126. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J.Clin.Invest. 1991;87:1541-1546.

127. Kamei T, Ozaki T, Kawaji K, et al. Production of interleukin-5 and granulocyte/macrophage colony-stimulating factor by T cells of patients with bronchial asthma in response to Dermatophagoides farinae and its relation to eosinophil colony-stimulating factor. Am.J Respir.Cell Mol.Biol. 1993; 9:378-385.

128. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma . J.Allergy Clin.Immunol. 1993;92:313-324.


[Seite 119↓]

129. Bennich HH, Ishizaka K, Johansson SG, Rowe DS, Stanworth DR, Terry WD. Immunoglobulin E: a new class of human immunoglobulin. Immunology 1968 ;15:323-324.

130. Johansson SG. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967;2:951-953.

131. Ishizaka K, Ishizaka T. Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol 1967;99: 1187-1198.

132. Ishizaka K, Ishizaka T, Hornbrook MM. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity . J Immunol 1966;97:75-85.

133. Howarth PH, Durham SR, Kay AB, Holgate ST. The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma . J.Allergy Clin.Immunol . 1987;80 :703-711.

134. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N.Engl.J Med. 1989;320:271-277.

135. Illi S, Von Mutius E, Lau S, et al. The pattern of atopic sensitization is associated with the development of asthma in childhood. J Allergy Clin Immunol 2001.Nov.; 108.(5.Part.1.): 709-714.

136. Kulig M, Bergmann R, Niggemann B, Burow G, Wahn U. Prediction of sensitization to inhalant allergens in childhood: evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study. Clin Exp.Allergy 1998;28:1397-1403.

137. Ishizaka T, Ishizaka K. Biology of immunoglobulin E. Prog Allergy 1975;19:60-121.

138. Oltz EM. Regulation of antigen receptor gene assembly in lymphocytes. Immunol Res 2001.; 23.(2.-3. 121.-33.

139. Alt FW, Blackwell TK, DePinho RA, Reth MG, Yancopoulos GD. Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev 1986;89 5-30

140. Manis JP, Tian M, Alt FW. Mechanism and control of class-switch recombination. Trends.Immunol 2002.Jan.; 23.(1.) 31-39.


[Seite 120↓]

141. Radbruch A. The molecular basis of immunoglobulin class switching: switch transcription versus switch recombination. Immunol Res. 1991;10:381-385.

142. Vercelli D, Jabara HH, Arai K, Geha RS. Induction of human IgE synthesis requires interleukin 4 and T-B cell interaction involving the T cell receptor/CD3 complex and MHC-class II antigens. J Exp Med 1989 ;169:1295-1307.

143. Vercelli D. Novel insights into class switch recombination. Curr.Opin.Allergy Clin Immunol 2002 Apr.; 2.(2.):147-151.

144. Vercelli D. Immunoglobulin E and its regulators. Curr.Opin.Allergy Clin Immunol 2001.Feb.; 1.(1.): 61-65.

145. Laman JD, Claassen E, Noelle RJ. Functions of CD40 and its ligand, gp39 (CD40L). Crit.Rev Immunol 1996;16:59-108.

146. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992;13: 431-433.

147. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, deSaint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 1993;361:541-543.

148. Jabara HH, Schneider LC, Shapira SK, et al. Induction of germline and mature Ce transcripts in human B cells stimulated with rIL-4 and EBV. J Immunol 1990 ;145:3468-3473.

149. Jabara HH, Ahern DJ, Vercelli D, Geha RS. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J Immunol 1991;147: 1557-1560.

150. Hudak SA, Gollnick SO, Conrad DH, Kehry MR. Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. Proc Natl Acad Sci U S A 1987;84: 4606-4610.

151. Lebman DA, Coffman RL. Interleukin 4 causes isotype switching to IgE in T cell- stimulated clonal B cell cultures . J Exp Med 1988;168:853-862.

152. Pene J, Rousset F, Briere F, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc.Natl.Acad.Sci.U.S.A 1988;85:6880-6884.


[Seite 121↓]

153. Finkelman FD, Katona IM, Urban JF, Jr., Snapper CM, Ohara J, Paul WE. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc.Natl.Acad.Sci.U.S.A. 1986;83:9675-9678.

154. Finkelman FD, Katona IM, Urban JF, Jr., et al . IL-4 is required to generate and sustain in vivo IgE responses. J.Immunol . 1988;141:2335-2341.

155. Coyle AJ, Le Gros G, Bertrand C, et al . Interleukin-4 is required for the induction of lung Th2 mucosal immunity . Am.J Respir.Cell Mol.Biol . 1995;13: 54-59.

156. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.

157. Lawrence RA, Allen JE, Gregory WF, Kopf M, Maizels RM. Infection of IL-4-deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response. J Immunol. 1995;154:5995-6001.

158. Wills Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma [see comments ]. Science 1998; 282:2258-2261.

159. Zurawski G, De Vries JE. IL-13, an IL-4-like cytokine that acts on monocytes and B cells, but not on T cells . Immunol.Today 1994; 15: 19-26.

160. Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition y interferon-gamma. J.Immunol. 1986;136: 949-954.

161. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J.Immunol. 1988;140:1022-1027.

162. Pene J, Rousset F, Briere F, et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J.Immunol. 1988 ;141: 1218-1224.

163. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79:3101-3109.

164. Sanderson CJ. The biological role of interleukin 5. Int.J.Cell Cloning 1990;8 Suppl 1: 147-53; discussion 153-4.


[Seite 122↓]

165. Sanderson CJ, O'Garra A, Warren DJ, Klaus GG. Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc.Natl.Acad.Sci.U.S.A. 1986;83:437-440.

166. Sanderson CJ, Warren DJ, Strath M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med 1985;162:60-74.

167. Strath M, Sanderson CJ. Detection of eosinophil differentiation factor and its relationship to eosinophilia in Mesocestoides corti-infected mice. Exp Hematol 1986; 14:16-20.

168. Devos R, Plaetinck G, Cornelis S, Guisez Y, Van der Heyden J, Tavernier J. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease. J Leukoc.Biol. 1995 ;57:813-819.

169. Drazen JM, Arm JP, Austen KF. Sorting out the Cytokines of Asthma. J.Exp.Med. 1996;183: 1-5.

170. Hamelmann E, Gelfand EW. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness . Int Arch Allergy Immunol 1999;120:8-16.

171. Koike M, Takatsu K . IL-5 and its receptor: which role do they play in the immune response?. [Review]. Int.Arch.Allergy Immunol. 1994;104:1-9.

172. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am.J Respir.Crit.Care Med. 1997;156: 704-708.

173. Till S, Dickason R, Huston D, et al . IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin.Immunol. 1997; 99:563-569.

174. Cockcroft DW . Airway hyperresponsiveness and late asthmatic responses. Chest 1988 ;94:178-180.

175. Cockcroft DW. Allergen-induced late asthmatic responses and increased airway responsiveness. Allergy Proc. 1992; 13:1-2.


[Seite 123↓]

176. Gaga M, Frew AJ, Varney VA, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J Immunol 1991;147: 816-822.

177. Frew AJ, Kay AB. Eosinophils and T-lymphocytes in late-phase allergic reactions. J Allergy Clin Immunol 1990;85: 533-539.

178. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-4164.

179. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92: 397-403.

180. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N.Engl.J.Med 1992;326:298-304.

181. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J.Immunol. 1986 ;136: 2348-2357.

182. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp.Med . 1987;166: 1229-1244.

183. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones . J Immunol 1987;138:3688-3694.

184. Garside P, Mowat AM. Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence? Immunol Today 1995;16: 220-223.

185. Del Prete G. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 1998;16:427-455.

186. Flavell RA, Rincon M, Zheng WP, et al. The regulation of CD4 T cell differentiation. Eur.Cytokine.Netw. 1998 ;9: 26-32.


[Seite 124↓]

187. Seder RA, Paul WE, Davis MM, et al . The presence of interleukin 4 duing in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice . J Exp Med 1992;176 :1091-1098.

188. Gazzinelli RT, Wysocka M, Hayashi S, et al . Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii . J Immunol 1994; 153:2533-2543.

189. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A . Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc.Natl.Acad.Sci.U.S.A. 1993 ;90:6115-6119.

190. Bradding P, Roberts JA, Britten KM, et al . Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am.J.Respir.Cell Mol.Biol 1994; 10:471-480.

191. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores . Nature 1989;339:64-67.

192. Romagnani S, Parronchi P, D'Elios MM, et al . An update on human Th1 and Th2 cells. Int Arch Allergy Immunol 1997;113:153-156.

193. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995;15:121-129.

194. Romagnani S . The Th1/Th2 paradigm . Immunol Today 1997;18:263-266.

195. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol . 1996;80:225-235.

196. Wanner A, Abraham WM, Douglas JS, Drazen JM, Richerson HB, Ram JS. Models of airway hyperresponsiveness . Am Rev Respir Dis 1990; 141:253-257.

197. Cockcroft DW. Airway responses to inhaled allergens. Can.Respir.J 1998 ;5 Suppl A 14A-7A 14A-17A.

198. Heusser CH, Wagner K, Bews JP, et al. Demonstration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation . Int Arch Allergy Immunol 1997;113:231-235.


[Seite 125↓]

199. Laberge S, Rabb H, Issekutz TB, Martin JG. Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat . Am.J Respir.Crit.Care Med 1995;151:822-829.

200. Fryer AD, Costello RW, Yost BL, et al . Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways . J Clin.Invest . 1997;99:2036-2044.

201. Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma . Am.Rev Respir.Dis 1993; 148 :1623-1627.

202. Van Oosterhout AJ, Van Ark I, Folkerts G, et al. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am.J Respir.Crit.Care Med. 1995;151:177-183.

203. Hamelmann E, Takeda K, Gelfand EW. Animal Models of Airway Hyperresponsiveness. In: Shevach E, ed. New York: John Wiley and Sons, Inc., 2000;

204. Folkerts G, Van Esch B, Janssen M, Nijkamp FP . Virus-induced airway hyperresponsiveness in guinea pigs in vivo: study of broncho-alveolar cell number and activity . Eur.J Pharmacol 1992;228 :219-227.

205. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest. 1997 ;100:226-233.

206. Martin TR, Gerard NP, Galli SJ, Drazen JM. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl.Physiol 1988 ;64 :2318-2323.

207. Hamelmann E, Schwarze J, Takeda K, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am.J Respir.Crit.Care Med 1997 ; 156:766-775.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
27.08.2004